Clinical rheumatology · 2025
Machine learning based on systemic inflammation response index and risk of cardiovascular disease in gout: a retrospective study and clinical validation.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Qiang, Yu Xuan-Hua, Zhang Wei-Zhen, Lyu Xue-Bing, Lin Hu-Han, Zeng Shan-Ting, Liu Chang-Quan, Huang Hui-Juan, Deng Wei-Zhe
Аннотация
OBJECTIVE: Gout is a chronic inflammatory disease, and cardiovascular disease (CVD) is regarded as one of its complications. The aim of our study was to explore the association between systemic inflammation response index (SIRI) and the risk of CVD in gout.
METHODS: Six cycles of NHANES data were analyzed. Machine learning algorithms were employed to screen covariates, followed by SHAP interpretation to assess variable importance. Participants with gout were stratified by SIRI quartiles, and logistic regression was performed to evaluate CVD risk. RCS were applied to assess nonlinear trends, while discrimination, calibration, and clinical utility were evaluated using ROC, DCA, and calibration curve. Additionally, the Framingham risk score (FRS) model was integrated with SIRI, and model improvement was quantified via net reclassification improvement and integrated discrimination improvement.
RESULTS: Among 1260 participants with gout, 436 (weighted 28.77%) had CVD comorbidities. A linear positive association was observed between SIRI and CVD risk (P for nonlinear = 0.824), with each 1-unit increase in SIRI corresponding to 29.7% higher CVD risk (OR = 1.297, 95% CI 1.073-1.568). Participants in the highest SIRI quartile Q4 (OR = 2.060, 95% CI 1.141-3.721) exhibited increased CVD risk compared to Q1. The final model demonstrated robust discrimination (AUC = 0.755, 95% CI 0.729-0.783). Incorporating SIRI into the NHANES and clinical datasets improved the discrimination of the FRS model by 5.2% and 1.9%.
CONCLUSION: A positive linear association was identified between SIRI and CVD risk in gout patients. The model constructed based on machine learning demonstrated comparable robustness to the FRS model in predicting CVD. These findings provide a theoretical and empirical foundation for early CVD identification, prevention, and management in this population. Key Points • The positive linear association between the systemic inflammation response index and cardiovascular disease, as well as its subtypes in patients with gout. • SIRI can serve as a valuable complement to the Framingham risk score model.
METHODS: Six cycles of NHANES data were analyzed. Machine learning algorithms were employed to screen covariates, followed by SHAP interpretation to assess variable importance. Participants with gout were stratified by SIRI quartiles, and logistic regression was performed to evaluate CVD risk. RCS were applied to assess nonlinear trends, while discrimination, calibration, and clinical utility were evaluated using ROC, DCA, and calibration curve. Additionally, the Framingham risk score (FRS) model was integrated with SIRI, and model improvement was quantified via net reclassification improvement and integrated discrimination improvement.
RESULTS: Among 1260 participants with gout, 436 (weighted 28.77%) had CVD comorbidities. A linear positive association was observed between SIRI and CVD risk (P for nonlinear = 0.824), with each 1-unit increase in SIRI corresponding to 29.7% higher CVD risk (OR = 1.297, 95% CI 1.073-1.568). Participants in the highest SIRI quartile Q4 (OR = 2.060, 95% CI 1.141-3.721) exhibited increased CVD risk compared to Q1. The final model demonstrated robust discrimination (AUC = 0.755, 95% CI 0.729-0.783). Incorporating SIRI into the NHANES and clinical datasets improved the discrimination of the FRS model by 5.2% and 1.9%.
CONCLUSION: A positive linear association was identified between SIRI and CVD risk in gout patients. The model constructed based on machine learning demonstrated comparable robustness to the FRS model in predicting CVD. These findings provide a theoretical and empirical foundation for early CVD identification, prevention, and management in this population. Key Points • The positive linear association between the systemic inflammation response index and cardiovascular disease, as well as its subtypes in patients with gout. • SIRI can serve as a valuable complement to the Framingham risk score model.